BCL2L1 and melanoma: Notably, a similar percentage of cell viability was found in control cells, silenced or WEHI-539 treated melanoma BCL-XL overexpressing clone (Fig. S4), thus demonstrating that the observed reduction of 3D spheroid formation after genetic or pharmacological inhibition of BCL-XL was not due to apoptosis induction.